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Saudi ArabiaAbstract Introduction: Drug promotion has to contribute to a more rational use of drugs. Con-
cerns arise if promotion negatively inﬂuences prescribing/dispensing pattern. It is warranted to
assess exposure and attitudes to, and acceptance of, drug promotion among pharmacists and phy-
sicians.
Methodology: Adopting a randomized, multiple site and cross-sectional survey study, question-
naires (n= 250) were completed by physicians and pharmacists to investigate the exposure, accep-
tance or skepticism of Saudi physicians/pharmacists to drug promotion as well as their perception
of the appropriateness of gifts and to check if they had any teaching/training about dealing with
medical representatives (MRs) and Pharma promotion.
Results: Signiﬁcantly more pharmacists than physicians (32% vs. 23%; p< 0.05) reported being
taught or educated about the ethics of drug promotion. The experience level was signiﬁcantly asso-
ciated with the teaching or training that the physicians and pharmacists received. Conference reg-
istration fees and drug samples were the most appropriate promotional gift for the physicians (67%
and 66%, respectively; p< 0.01) whereas for pharmacists, the drug sample was considered the most
suitable donation (79%). More pharmacists perceived drug companies as a useful way to gain
knowledge about drugs than physicians (75% vs. 65%; p< 0.01). A higher proportion of both
groups were accepting drug promotion than those skeptical about it.
Conclusion: The majority of physicians or pharmacists participating in this study have received
gifts from pharmaceutical companies. The drug samples and printed educational materials are the
Pharmacists’ and physicians’ perception and exposure to drug promotion 529most widely accepted gifts. Recent graduates and those with few years of experience had higher
teaching/training than experienced physicians and pharmacists in pharmaceutical promotion ethics
and tactics to deal with MRs. On the other hand, experienced healthcare team were more
approached and targeted by pharmaceutical companies and MRs. It is highly recommended to
implement courses/discussion groups on the ethical interaction between healthcare professionals
and pharmaceutical companies in the curriculum of both pharmacy and medicine. Updating the
physicians and pharmacists after graduation, as part of continued medical/pharmacy education,
will eventually improve the healthcare professionals’ capability to act to the patients’ welfare.
ª 2014 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Drug promotion refers to all informational and persuasive
endeavours by manufacturers and distributors, ultimately
leading to provoke the supply, purchase and/or use of medica-
tions (WHO, 1998). Drug promotion has been suggested so
that healthcare professionals have access to information they
need about medicine and that medicines are prescribed and
used in the welfare and beneﬁt of patients.
It was estimated that the pharmaceutical promotion and
marketing expenditure in the USA, in 2000 was $15.7 billion
which was 20–30% of sales turnover and 2- to 3-times that
of research and development (National Institute for Health
Care Management, 2001). Half of this expenditure is directed
to the price of medicine samples (50.3%) and detailing visits
to physicians (25.5%).
Physicians prescribe drug products that are called
‘‘prescription drugs’’ whereas the pharmacists dispense non-
prescription drugs or ‘‘over-the counter medications; OTC’’.
The detailing visits of medical representatives (MRs) to physi-
cians and pharmacists combined with other promotional activ-
ities such as gifts, sponsored meetings and advertising might
affect the attitudes towards the drug company and its medical
products.
Communications and interactions between pharmaceutical
companies and physicians/pharmacists regarding drug promo-
tion and marketing have been lately the focus of interest from
an ethical point of view. These interactions are pervasive and
often inﬂuential and beneﬁcial for the patient but they may
turn into some undesirable consequences (Hall et al., 2006).
Concerns are about if drug promotion is inducing doctors to
prescribe speciﬁc drugs, if it is driving pharmacists to dispense
expensive drugs when less expensive drugs might be better in
some cases, and if it leads to the inappropriate clinical use of
some drugs (Lexchin, 1993).
Previous research indicated that doctors/pharmacists who
receive gifts are more positive towards the company and more
likely to prescribe/dispense the company’s products (Ashker
and Burkiewicz, 2007; Banks and Mainous, 1992; Brett
et al., 2003). It has been suggested that physicians who rely
on drug company information, through drug detailers (MRs)
or promotional literature, prefer expensive brands, adopt new-
er medicines more quickly, show more inappropriate prescrib-
ing and write more prescriptions that their colleagues
(Lexchin, 1993). Ethical concerns have been raised about the
impact that the pharmaceutical companies may have on
physicians and pharmacists and the outcome it could bring
on their prescribing and dispensing practice if they got usedto receiving gifts (Adair and Holmgren, 2005; Brett et al.,
2003) and growing positive attitudes and a feeling of commit-
ment towards pharmaceutical companies (Rogers et al., 2004;
Rosner, 2000; Wazana, 2000). A very recent Saudi study by
Alosaimi et al. indicated that gift acceptance is familiar for
physicians working in Saudi Arabia (Alosaimi et al., 2013).
We expanded this by comparing the perception of physicians
and pharmacists towards gifts from Pharma Industry.
The aim of the present study is to investigate the exposure,
acceptance or skepticism of physicians/pharmacists to drug
promotion as well as their perception of the appropriateness
of gifts and to determine if physicians/pharmacists (especially
the new graduates) have had any teaching/training during their
study about dealing with medical representatives and Pharma
promotion.2. Methodology
2.2. Survey development and distribution
A self-administered questionnaire was developed both in paper
as well as in electronic form (attached; Appendix A) (https://
docs.google.com/forms/d/1h3ww_Vu5W8fGbKazt8v0KV8o
M9IeTjS-pGSPKuQv07Y/viewform). The survey was con-
ducted from September to November 2013. Results were anon-
ymous, all items are obligatory to ﬁll. Completion of the
survey was tracked with 3 reminders sent out at approximately
3-week interval. Physicians and pharmacists were queried on 5
drug promotion-related issues namely: (1) demographic infor-
mation about the physician/pharmacist (age, gender, national-
ity and residence); (2) exposure to training about drug
company promotion and interactions, and encounters with
pharmaceutical representatives; (3) exposure to different drug
company interactions and gifts and the number of times they
participated in these interactions; (4) perceptions of appropri-
ateness of various drug company gifts assessed on a 12 item,
3-point scale (appropriate, inappropriate, and neutral); and
(5) attitudes about pharmaceutical promotion measured as
agreement with 9 statements (5 revealing acceptance of drug
promotion and 4 revealing skepticism) on a 3-point scale
(agree, disagree, and neutral).2.3. Study design
The design was a randomized, multiple site and cross-sectional
survey. The study conformed to the ethical principles of the
Table 1 Socio-demographic characteristics (n= 250).
Characteristics Number of participants (%)
Occupation
Physician 137 (54.8)
Pharmacist 113 (45.2)
Gender
Male 148 (59.2)
Female 102 (40.8)
Age
20–29 108 (43.2)
30–39 76 (30.4)
40–49 44 (17.6)
>50 22 (8.8)
Nationality
Saudi 110 (44)
Egyptian 100 (40)
Sudanese 9 (3.6)
Jordanian 6 (2.4)
Syrian 6 (2.4)
Indian 9 (3.6)
Pakistanis 3 (1.2)
Others 2 (0.8)
Years of experience
1–5 121 (48.4)
5–10 55 (22)
>10 74 (29.6)
Residence
Rural 86 (34.4)
Urban 164 (65.6)
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2.4. Data collection
More than 400 questionnaires were distributed. Response rate
was 63%.
2.5. Setting
Visits were performed at hospitals, health centres and pharma-
cies. Physicians from all specialities and community pharma-
cists were included.
2.6. Data analysis
The level of agreement with statements was determined by
combining and comparing those who responded ‘‘Disagree’’
and ‘‘Neutral’’ to those who ‘‘Agree’’. Similarly those who re-
sponded ‘‘Inappropriate’’ and ‘‘Neutral’’ were combined and
compared to those who reported ‘‘Appropriate’’.
2.7. Statistical analysis
SPSS v. 16.0* statistical software (SPSS Inc., Chicago, USA)
was used. The Chi-square test was used for comparison of pro-
portions while Student’s t-test was used in case of continuous
data. The signiﬁcance level was set as p< 0.05 unless other-
wise stated.
3. Results
A total of 250 staff completed the questionnaires, of these, 137
physicians and 113 pharmacists participated in the study (Ta-
ble 1). A signiﬁcant (p< 0.05) majority of the respondents
were males (59.2%) and the rest (40.8%) were females. The
greatest proportion of the participants was young age (20–
29 years old) physicians and pharmacists (43.2%), Saudi
nationals (44%), with 1–5 years of experience (48.4%) who live
in urban areas (66%); signiﬁcant at p< 0.05. This was attrib-
uted to the inclusion of newly graduated male students from
College of Medicine and College of Pharmacy, Saudi Arabia.
3.1. Exposure
Almost all of the physicians and pharmacists (99.5%) reported
participation in at least one of the mentioned promotional
activities offered by pharmaceutical drug companies. As shown
in Table 2, higher percentages of physicians than pharmacists
were exposed to gifts from Pharmaceutical companies. Glossy
advertisement materials (62%) and free drug samples (42%)
were the gifts most commonly received by physicians whereas
pharmacists reported that the most frequent gifts they received
from pharmaceutical companies were non-educational gifts
(24.8%), meals (20%) and glossy adverts (18%).
3.2. Education/training
Table 3 shows that signiﬁcantly more (p< 0.05) pharmacists
(32%) than physicians (23%) reported being taught or edu-cated about the ethics of drug promotion as well as having per-
sonal friendship with medical representative (MRs) 32% as
compared to 28% of physicians (p< 0.01). On the other hand,
signiﬁcantly higher percent of physicians (34%) mentioned of
being contacted by MRs within pharmacy ward and within
Health Sciences Center (p< 0.01). Insigniﬁcant difference
(p< 0.01) was revealed between physicians and pharmacists
in teaching about how to interpret drug promotional material
or how to deal with MRs.
Among the different demographic properties, the experi-
ence level was signiﬁcantly associated with the teaching or
training that the physicians and pharmacists received. Fig. 1
reveals that a higher number of newly graduated physicians
and pharmacists (with 1–5 years of experience only) have re-
ceived teaching in their studies about the ethics and how to
handle drug promotion even though they might have had a
friendship with MRs. On the other hand, experienced physi-
cians and pharmacy staff were the one most commonly ap-
proached by MRs (41% vs. 32%; p< 0.01).
3.3. Appropriateness of gifts
As shown in Fig. 2, the promotional gifts most appropriate in
the opinion of the majority of physicians were conference reg-
istration fees and free drug samples (67% and 66%, respec-
tively; p< 0.01). Whereas for pharmacists, Fig. 3 shows that
the drug sample was the most suitable donation (79%) fol-
lowed by text book (67%) and notepad (63%) (p< 0.05).
Interestingly, expensive gifts (>50 SAR or 20 to 150 SAR)
were considered to be the least appropriate by the participants
Table 2 Proportion of physicians and pharmacists receiving different promotional gifts from pharmaceutical companies.
Activity/gift Proportion exposed to/participated in drug promotion by pharmaceutical companies
Physician Pharmacist
N % N %
Participated in meals 29 21.2 23 20.4
Received non-educational gift 38 27.7 28 24.8
Received reprint/glossy advert 85 62.0 20 17.7
Received personal drug sample 57 41.6 15 13.3
Taken part in social outing 25 18.2 9 8.0
Received book 10 7.3 11 9.7
Participated in workshop 17 12.4 10 9.5
Conference registration fee paid 14 10.2 8 7.1
Participating in research project 5 3.6 7 6.2
Received stethoscope 14 10.2 – –
Table 3 Physicians and pharmacists trained or educated about drug promotion or contact with MRs.
Number (%) of
participants saying ‘‘yes’’
Fisher’s
exact test (p)
Physician Pharmacist
Have you received any teaching in your studies about the ethics or
eﬀects of drug company promotion
57 79 0.02
(22.8%) (31.6%)
Have you ever received any teaching in your studies about how to
handle or interpret drug promotional material and/or MRs?
60 64 0.05
(24%) (25.6%)
Do you have a personal friendship with MRs? 70 82 0.02
(28%) (32%)
Have you ever been approached by MRs whilst being pharmacy
placement/ward round
85 46 0.001
(34%) (18.4%)
Have you ever been approached by MRs within the Health Sciences
Center
85 44 0.001
(34%) (17.6%)
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Generally, there was a similar pattern in perception of both
groups about the appropriateness of gifts but with different
proportions in each group (insigniﬁcant difference at
p< 0.05).
3.4. Acceptance and skepticism attitudes towards drug
promotion
The perception of physicians and pharmacists towards phar-
maceutical promotion is shown in Figs. 4 and 5 respectively.
At a glance, the data revealed almost the pattern in both
groups with higher proportion accepting drug promotion than
those skeptics about it.
By thoroughly analysing the data in the 2 groups, it was
obvious that signiﬁcantly more pharmacist participants per-
ceived drug companies as a useful way to gain knowledge
about drugs than physicians (75% vs. 65%; p< 0.01). Like-
wise, this trend was observed in statements about pharmaceu-
tical companies’ talks being educational and helpful and the
information given by MRs as being trustable. Nevertheless,
statements about minimal effects gifts have on staff got higher
agreement percent among physicians than pharmacists (20%
vs. 14%; p< 0.05).
Regarding the skeptic attitude of both pharmacists and
physicians, by comparing Figs. 4 and 5 it was obvious thathigher degree of skepticism was revealed by pharmacists than
by physicians. More supporters from pharmacists than
from physicians to statements about drug companies acting
unethically (39% vs. 31%), increased prescribing/dispensing
of certain drugs (49% vs. 34%) and higher prices of medication
as a consequence of getting gift (36% vs. 37%) were found.
The greatest response (>58%) of both physicians and
pharmacists agreed that most drug company talks are biased
(63% vs. 58%, respectively; mean agreement score 1.8 vs. 2;
p< 0.05), there was other indication that they were otherwise
skeptical of pharmaceutical promotion.
4. Discussion
The impact of pharmaceutical promotion on prescribing and
dispensing medicaments cannot be disregarded or overlooked.
In the USA, pharmaceutical industries use gifts to physicians
as marketing strategy (McFadden et al., 2007). It is of para-
mount interest to prepare healthcare professionals who deal
with drugs (physicians and pharmacists) by training and educat-
ing them with the ethical guidelines for drug promotion (WHO,
1998; IFPMA, 2000) and then to monitor their interaction.
A number of studies have investigated perceptions towards
the potential inﬂuence of MRs on resident and practicing phy-
sicians (Lewin-Fetter, 1997; Lexchin, 1993; Lichstein et al.,
1992; McKinney et al., 1990) while others examined the views
Figure 1 Relation between experience of physicians and pharmacists and the teaching they received about drug promotion and exposure
to drug promotion. After Chi-square test was applied, only statements where experience years were signiﬁcantly associated with agreement
are shown. Experience 1–5 years, 5–10 years and more than 10 years.
Figure 2 Perceived appropriateness of promotional gifts as
indicated by physicians (n= 137). Figure 3 Perceived appropriateness of promotional gifts as
indicated by Pharmacists (n= 113).
532 N.M. Zakiof medical students (Monaghan et al., 2003; Sarikaya et al.,
2009; Sierles et al., 2005; Soyk et al., 2010; Wofford and
Ohl, 2005). In Saudi Arabia, only one study examined the var-
iability in accepting different types of gifts by clinical specialty
and job rank among physicians (Alosaimi et al., 2013) but
none has investigated perception of physicians and pharma-
cists towards Pharma gifts and the teaching they received so
studies addressing the perception of drug promotion are lack-
ing; which makes our study unique. The Saudi FDA (SFDA)
has newly published Drug Advertising And Promotion Guid-
ance: Guidance & Requirements Directory of Licensing Phar-
maceutical and Herbal Product Advertising (Accessed 18November, 2013a) and will soon publish Saudi code of phar-
maceutical promotional practices in the KSA (Accessed 18
November, 2013b). We have chosen to conduct this study on
physicians and pharmacists and to include a large number of
newly graduated students from College of medicine and Col-
lege of Pharmacy (43% of participants in the study).
Our study shows that pharmacists reported greater training
on drug promotion ethics and interpretation than physicians.
This could be due to that drug marketing and promotion is
one career for pharmacists whereas physicians are the prime
targets of marketing. This is in agreement with Mintzes who
reported that pharmacy schools tend to devote more time to
Figure 4 Physicians’ acceptance and skepticism towards drug promotion by pharmaceutical companies and/or MRs (n= 137).
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2005). However, it contradicts a study done on students in
Kuwait which shows that physicians students have more edu-
cation in this regard (Ball and AL-Manea, 2007).
Almost all the participants in this study reported receiving
gifts from pharmaceutical companies. Nevertheless physicians
remarkably reported greater exposure than pharmacists. This
is due to that industrial companies realize that physicians can
be the powerful advocates for their products but raises concerns
regarding conﬂict-of-interest at medical centres. Regarding the
appropriateness of gifts, gifts were considered appropriate by
the staff with least percent given to expensive gifts (>50 SAR)
whereas stationary, educational gifts and drug samples have
the greatest percentage of supporters. The participants in our
study hence perceive such less costly promotional gifts from
industry, to be beneﬁcial to patients. Previous studies similarly
revealed that accepting low-cost gifts such as free drug samples,
stationary, and free meals was more frequent than accepting
higher-price gifts. (Halperin et al., 2004; Lieb and Brandtonies,
2010; McNeill et al., 2006; Misra et al., 2010; Saito et al., 2010).
The ﬁnding that the experience level was signiﬁcantly asso-
ciated with the teaching or training received by physicians and
pharmacists might be attributable to that new generations
have been exposed to updated curricula in Medicine and
PharmD programmes implemented in University that complies
with international guidelines. On the other hand older genera-
tions might have not received such teaching in their undergrad-uate studies especially in the absence of formal ethical codes
governing pharmaceutical promotion in SA and the relation-
ships between health professionals and pharmaceutical indus-
try (soon to be published by SFDA) or that the skills for
interacting with MRs may not have been integrated as part
of the traditional medical /pharmacy college curriculum.
Appropriate curriculum of future health professionals is cru-
cial to get them ready to play their role as physicians and phar-
macists, in making or inﬂuencing drug-related decisions in the
face of medication promotion as well as to prepare them for
ethical interaction with drug companies or MRs as per the
guidelines (Accessed 16 November, 2013a,b; WHO, 1998).
Innovative teaching strategies involving medical representa-
tives (MRs) or promotional material have been demonstrated
to bring constructive perception and skills in interpreting pro-
motional information (Wilkes and Hoffman, 2001). It is note-
worthy that Alosaimi et al. reported no signiﬁcant differences
in the overall gift acceptance by job rank (Consultant, Special-
ist, resident) but signiﬁcant differences in type-speciﬁc gift
acceptance by job rank and specialty (Alosaimi et al., 2013).
High percentage of staff perceived information from phar-
maceutical companies /MRs to have educational value.
Although both pharmacists and physicians mostly felt that
drug company sponsored talks were biased in favour of the
company’s product(s), they did not appear to restrict contact
with MRs nor to feel that they would be improperly affected
in their professional practice. The ﬁnding that the experience
Figure 5 Pharmacists’ acceptance and skepticism towards drug promotion by pharmaceutical companies and/or MRs (n= 113).
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macists’ perception about drug promotion by MRs or pharma-
ceutical companies with wider acceptance among young
professionals with 1–5 years of experience might be attributed
to awareness and preparedness they gained from their college
studies. Similar ﬁndings were recently reported in the literature
(Ball and AL-Manea, 2007; Sierles et al., 2005, 2009; Soyk
et al., 2010). The low degree of skepticism, while recognizing
that there is a bias in drug company information, suggests that
the staff may not realize the inﬂuence that exposure to drug
promotion can have on their professional behaviour.
Based on the ﬁndings here, it is recommended to implement
courses/discussion groups on the ethical interaction between
health professionals and pharmaceutical companies in the for-
mal curriculum of both pharmacy and medicine. In addition,
the physicians and pharmacists after graduation should be up-
dated, as part of continued medical/pharmacy education, to
improve the health professionals’ capability to act in the best
interests of patients.5. Conclusion
The majority of physicians or pharmacists participating in this
study have received gifts from pharmaceutical companies. The
drug samples and printed educational materials are the most
widely accepted gifts. Recent graduates and those with few
years of experience had higher teaching/training than experi-
enced physicians and pharmacists in pharmaceutical promo-
tion ethics and tactics to deal with MRs. On the other hand,
experienced healthcare team were more approached and tar-
geted by pharmaceutical companies and MRs. Further re-
search should study the implementation of education about
ethical promotion and appropriate interaction with MRs in
the formal curriculum of both pharmacy and medicine pro-
grams as well as in continued medical/pharmacy education,
to improve their ability to act in the best interests of patients,
promote the rationale use of drugs and avoid conﬂict-of-
interest.
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A.1. Exposure and attitude to drug promotion, Saudi Study
Consent statement: This survey is conducted to study exposure
and attitudes to, and acceptance of, drug promotion among
pharmacy and medical staff. The collected information will
anonymously recorded (no need to write your name) and only
used for research purposes. As we go through the questionnaire,
please feel free not to answer if you do not wish to give addi-
tional information. Your cooperation is highly appreciated.
A.2. (Please ﬁll in the required information and ONLY TICK
THE MOST YOU THINK IS THE RIGHT ANSWER)
1- Serial no.: ……………………………………………….
2- Gender:   Male   (  )  - Female   (    )
3- Age: ……………………………………………………..
4- Nationality: …………………………………………………………
5- Residence:    Rural  (  ) -  Urban  (  )
6- Occupation:   medical (    )        Pharmacy (   ).
7- Years of professional experience: 1-5 (  ) , 5-10 (  ), more than 10 (   )
8- Have you received any teaching in your studies about the ethics or effects of 
drug company promotion Yes   (     )             No   (     )       
9- Have you ever received any teaching in your studies about how to handle or 
interpret drug promotional material and/or drug representatives (pharmaceutical 
company agents?  yes (    )      No (     )
10-Do you have a personal friendship with a medical representative? 
Yes (    )      No (     )
11-Have you ever been approached by Pharmaceutical company representatives 
when attending pharmacy placement/ward round? 
Yes (    )      No (     )
12-Have you ever been approached by pharmaceutical company representatives 
within the Health Sciences Center? Yes (    )     No (     )
A.3. Please ﬁll the most accurate selection (tick only one)
Agree Disagree Neutral 
1 The information provided by drug representatives 
about their company’s product can be trusted
2 The information from drug representatives is 
important for the pharmacy and medical staff
3 It is ok for pharmacy and medical staff to accept 
gifts from drug companies because drug companies 
have minimal influence on staff
4 Most talks sponsored by drug companies are helpful 
and educational
5 Drug companies are useful way to learn about new 
drugs
6 Drug companies sponsored talks are often biased in 
favor of their products
7 Gifts from drug companies to pharmacists/doctors 
lead to increased prices of medicines
8 Receiving gifts or food from pharmaceutical 
representatives increases the chance that I will 
eventually sell or recommend/prescribe the drug 
company’s products
9 Drug companies act unethically in promoting and 
advertising their productsA.4. Indicate the appropriateness of the promotional gift by
ticking one choice
Appropriate Inappropriate Neutral
1 Meal
2 Gift (> 50SAR)
3 Drug sample
4 Social trip
5 Gift (20-150 SAR)
6 Gift < 20 SAR
7 International Holiday
8 Pen/notepad
9 Conference Registration fees
10 Travel to conference
11 Stethoscope
12 Textbook
13 Stationary
14 Others ……………………..References
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